The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer
- 31 July 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 46 (1) , 29-32
- https://doi.org/10.1016/0090-8258(92)90190-t
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?Gynecologic Oncology, 1990
- Second Thoughts about Second-Look Laparotomy in Advanced Ovarian CancerNew England Journal of Medicine, 1990
- Cancer statistics, 1990CA: A Cancer Journal for Clinicians, 1990
- Use of CA 125 monoclonal antibody to monitor patients with ovarian cancerGynecologic Oncology, 1989
- Another look at the second- assessment procedure for ovarian epithelial carcinomaAmerican Journal of Obstetrics and Gynecology, 1987
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980